Keyphrases
Confidence Interval
84%
Benign Prostatic Hyperplasia
72%
Lower Urinary Tract Symptoms
67%
Randomized Controlled Trial
63%
Prostate Cancer
62%
Urology
55%
Cochrane Review
52%
Radical Retropubic Prostatectomy
48%
Urologists
37%
Risk Ratio
34%
Meta-analysis
30%
Certainty of Evidence
28%
Clinically Significant Prostate Cancer
28%
Robot-assisted Laparoscopic Radical Prostatectomy
27%
Clinical Practice Guidelines
27%
Evidence-based Medicine
26%
Grading of Recommendations
25%
Evaluation Assessment
25%
Assessment Development
25%
American Urological Association
24%
Systematic Meta-analysis
20%
Reporting Quality
20%
Radical Prostatectomy
19%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
18%
Methodological Quality
18%
MEDLINE
17%
Guideline Development
17%
Percutaneous Nephrolithotomy
16%
Prostate-specific Antigen
16%
Evidence-based
16%
Quality of Life
16%
Localized Prostate Cancer
16%
Patient Care
16%
Transurethral Resection of Prostate
15%
Prostatic Arterial Embolization
14%
Randomized Trial
14%
Radical Cystectomy
14%
Evidence-based Clinical Practice
13%
Surgical Management
13%
Bladder Cancer
13%
Androgen Deprivation Therapy
12%
Risk of Bias
12%
Surgical Intervention
12%
Renal Cell Carcinoma
12%
Prostatic Urethral Lift
12%
Placebo
12%
Review Authors
12%
Erectile Function
12%
Embase
11%
AUA Guidelines
11%
Medicine and Dentistry
Prostate Cancer
100%
Prostatectomy
75%
Systematic Review
69%
Randomized Controlled Trial
51%
Urology
48%
Prostate Hypertrophy
42%
Lower Urinary Tract Symptom
39%
Diseases
36%
Quality of Life
36%
Kidney Stone
34%
Urologist
26%
Adverse Event
24%
Evidence-Based Medicine
23%
Urinary System
19%
Neoplasm
19%
Transurethral Resection
18%
Malignant Neoplasm
18%
Prostate Specific Antigen
17%
Bladder Cancer
17%
Continence
17%
Meta-Analysis
17%
Arterial Embolization
15%
Robot-Assisted Prostatectomy
15%
Kidney Tumour
14%
Observational Study
14%
Biopsy Technique
14%
Percutaneous Nephrolithotomy
14%
Cystectomy
11%
Clear Cell Renal Cell Carcinoma
10%
Ureter Stone
10%
Diagnostic Test
10%
Body Mass Index
10%
Primary Outcome
10%
Dendritic Cell
10%
Health Care Cost
9%
Radical Retropubic Prostatectomy
9%
Subgroup Analysis
9%
Minimally Invasive Procedure
9%
Ureteroscopy
8%
Tumor
8%
Erectile Function
8%
Bleeding
8%
Critical Appraisal
8%
Overall Survival
8%
Patient Care
8%
Health Care
7%
Recurrent Disease
7%
Myeloid Cell
7%
Clinician
7%
Transurethral Microwave Thermotherapy
7%